Table 3.
Cisplatin | Cetuximab | Radiation | |
---|---|---|---|
Cell line | IC50 (μmol/L)a | Emax (%)a | ID50 (Gy)a |
LU-HNSCC-26 | 0.99 (0.89–1.1) | 18 (17–19) | 0.90 (0.85–0.95) |
LU-HNSCC-4 | 10 (9.0–11) | 29 (27–32) b | 16 (15–17) |
LU-HNSCC-5 | 20 (19–22) | 74 (68–80) b | 19 (18–21) |
LU-HNSCC-6 | 24 (23–26) | 51 (43–60) b | 23 (22–25) |
a(95% confidence interval)
bFrom reference [28]